Outcomes of kidney transplants and risk of infection transmission from increased infectious risk donors

被引:15
作者
Limkemann, Ashley J. [1 ]
Wolfe, Luke [1 ]
Sharma, Amit [2 ]
King, Anne L. [3 ]
Behnke, Martha [2 ]
Shah, Mili Jay [3 ]
Posner, Marc P. [2 ]
Cotterell, Adrian H. [2 ]
Bhati, Chandra S. [2 ]
Gupta, Ankur [2 ]
Kumar, Dhiren [3 ]
Gupta, Gaurav [3 ]
机构
[1] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA
[2] Virginia Commonwealth Univ, Div Transplant Surg, Richmond, VA USA
[3] Virginia Commonwealth Univ, Div Nephrol, Richmond, VA USA
关键词
increased infectious risk donors; kidney transplantation; long-term outcomes; HUMAN-IMMUNODEFICIENCY-VIRUS; EXPANDED CRITERIA DONORS; FOR-DISEASE-CONTROL; HEPATITIS-C VIRUS; ORGAN-TRANSPLANTATION; PROVIDER UTILIZATION; CENTER-EXPERIENCE; ADULT RECIPIENTS; DIALYSIS; DEATH;
D O I
10.1111/ctr.12761
中图分类号
R61 [外科手术学];
学科分类号
摘要
Concern over transmission of viral infections has been reported to result in higher discard rates of high infectious risk kidneys (HIR) although data on actual viral transmission rates are lacking. At our center, we performed 89 HIR and 533 non-HIR kidney transplants (KTs) between 2004 and 2011. Follow-up screening labs in recipients of HIR kidneys tested for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus did not reveal any cases of viral transmission over median follow-up of 4.3 years. Patient and graft outcomes were similar at 5 years between HIR and non-HIR KTs. An updated analysis of the Organ Procurement and Transplant Network (OPTN) registry of deceased-donor kidney transplants between 2008 and 2012 included 57 526 transplants was performed. Retrospective calculation of KDRI (kidney donor risk index) differed (P<.001) between all groups with median KDRI of 0.99 for HIR kidneys, 1.07 for non-HIR standard criteria donor kidneys, and 1.81 for non-HIR expanded criteria donor (ECD) kidneys. This was reflected in the significantly improved 5-year graft survival for HIR KTs when compared with non-HIR ECD KTs (84% vs 78%; P<.001). Our data can guide counseling of KT candidates about the safety and benefits of HIR kidneys.
引用
收藏
页码:886 / 893
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[2]  
[Anonymous], 2007, NY TIMES
[3]   Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation [J].
Bruchfeld, A ;
Wilczek, H ;
Elinder, CG .
TRANSPLANTATION, 2004, 78 (05) :745-750
[4]   Centers for Disease Control 'High-Risk' Donors and Kidney Utilization [J].
Duan, K. I. ;
Englesbe, M. J. ;
Volk, M. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (02) :416-420
[5]   Long-term outcome of en bloc pediatric kidney transplantation in adult recipients - up to 22 years of center experience [J].
Hafner-Giessauf, Hildegard ;
Mauric, Astrid ;
Mueller, Helmut ;
Eller, Philipp ;
Zigeuner, Richard ;
Iberer, Florian ;
Rosenkranz, Alexander R. ;
Eller, Kathrin .
ANNALS OF TRANSPLANTATION, 2013, 18 :101-107
[6]   Pretransplant Dialysis Duration and Risk of Death After Kidney Transplantation in the Current Era [J].
Helantera, Ilkka ;
Salmela, Kaija ;
Kyllonen, Lauri ;
Koskinen, Petri ;
Gronhagen-Riska, Carola ;
Finne, Patrik .
TRANSPLANTATION, 2014, 98 (04) :458-464
[7]   Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients [J].
Ison, M. G. ;
Llata, E. ;
Conover, C. S. ;
Friedewald, J. J. ;
Gerberg, S. I. ;
Grigoryan, A. ;
Heneine, W. ;
Millis, J. M. ;
Simon, D. M. ;
Teo, C. -G. ;
Kuehnert, M. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (06) :1218-1225
[8]   Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor Organs [J].
Kucirka, L. M. ;
Namuyinga, R. ;
Hanrahan, C. ;
Montgomery, R. A. ;
Segev, D. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) :629-635
[9]   Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs [J].
Kucirka, L. M. ;
Alexander, C. ;
Namuyinga, R. ;
Hanrahan, C. ;
Montgomery, R. A. ;
Segev, D. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) :620-628
[10]   Provider Utilization of High-Risk Donor Organs and Nucleic Acid Testing: Results of Two National Surveys [J].
Kucirka, L. M. ;
Namuyinga, R. ;
Hanrahan, C. ;
Montgomery, R. A. ;
Segev, D. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :1197-1204